CU6 Clarity scribes deal on delivery of copper 64 isotopes Clarity Pharmaceuticals Ltd has seen its share price leap after it announced a deal with Nusano to deliver Cu-64 isotopes Caroline Smith 2 days ago ASX News Healthcare Biotechnology
FRE 'Expansion' the watchword in Firebrick's sales-heavy quarter Firebrick Pharma Ltd has recorded a busy March quarter for 2025, marked by its move into retailing Nasodine in Singapore Caroline Smith 3 days ago ASX News Healthcare Biotechnology
NUZ Neurizon Therapeutics announces strong safety results in latest study Drug candidate NUZ-001 has shown strong safety characteristics in its latest human 3D brain model study, Neurizon Therapeutics (ASX:NUZ) has confirmed this week.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify,... Isaac McIntyre 5 days ago ASX News The Watchlist Healthcare Biotechnology
BP8 BPH Global pens offtake agreement with China-based manufacturer BPH Global (ASX:BP8) has this week signed a significant seaweed offtake agreement with Quanzhou Bailijie Biotechnology, a Chinese carrageenan producer.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, an... Isaac McIntyre 5 days ago ASX News The Watchlist Healthcare Biotechnology
NEU FDA OK for Neuren's first ever Phase 3 trial in children with Phelan-McDermid syndrome Neuren has popped 20% as the FDA greenlights its upcoming Phase 3 trial in children with Phelan-McDermid syndrome. Jonathon Davidson 5 days ago ASX News Healthcare Biotechnology
EMD Emyria opens second Empax centre in Perth to meet mental health demand Emyria Ltd has launched a second Empax clinic in Western Australia, aiming to support patients with depression and PTSD Caroline Smith 5 days ago ASX News Healthcare Biotechnology
AGN Argenica doses final patients in acute ischaemic stroke trial Argenica Therapeutics Ltd has taken an important step in completion of its Phase 2 trial to test the efficacy and safety of ARG-007 Caroline Smith 11 Apr 2025 09:53 (AEST) ASX News Healthcare Biotechnology
RCE Recce to raise $15.8M in trial funds through placement, entitlement offer Recce Pharmaceuticals Ltd plans to raise $5 million through a Placement to a private investor in Australia, and an Entitlement Offer Caroline Smith 10 Apr 2025 13:17 (AEST) ASX News Healthcare Biotechnology
OPT Opthea, with shares still suspended, cuts workforce by 65% after drug trials cancelled Troubled biotech stock Opthea (ASX:OPT), still in the process of crisis talks with investors, has flagged a workforce reduction of -65%. Jonathon Davidson 10 Apr 2025 11:07 (AEST) ASX News Healthcare Biotechnology
CSL Biotech stocks that survived April 2 feel the heat of Trump's new pharma threat If you thought a 104% tariff on China was bad enough, Trump’s found another way to make the markets about himself @ now confirming major tariffs on pharmaceuticals.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout th... Jonathon Davidson 09 Apr 2025 13:24 (AEST) ASX News Healthcare Biotechnology
NYR Study finds Nyrada's lead drug can prevent secondary brain injury Nyrada Inc has reported strong results from a collaborative study it has been engaged in regarding its lead candidate NYR-BI03 Caroline Smith 07 Apr 2025 10:24 (AEST) ASX News Healthcare Biotechnology
MSB Mesoblast dips on 'belief' it's not subject to US tariffs – despite Singaporean lab Mesoblast (ASX:MSB) has seen shares fall just shy of -3% heading into lunchtime trades despite apparent tariff relief. Jonathon Davidson 04 Apr 2025 12:31 (AEDT) ASX News Healthcare Biotechnology
CSL CSL survives a brutal sell-off but dips on US tariff response as investors eye pharma risk CSL Ltd (ASX:CSL) has seen shares fall nearly half a percent in afternoon trades on Thursday as the company responds to Trump's US tariffs. Jonathon Davidson 03 Apr 2025 13:27 (AEDT) ASX News Healthcare Biotechnology
